|
ZNF43 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.924600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.159000E-01 |
| Normal-vs-Stage2 |
2.112000E-01 |
| Normal-vs-Stage3 |
2.956000E-01 |
| Normal-vs-Stage4 |
1.960760E-01 |
| Stage1-vs-Stage2 |
3.391000E-01 |
| Stage1-vs-Stage3 |
4.540800E-01 |
| Stage1-vs-Stage4 |
2.500800E-01 |
| Stage2-vs-Stage3 |
6.808800E-01 |
| Stage2-vs-Stage4 |
9.339600E-01 |
| Stage3-vs-Stage4 |
7.266000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.099200E-01 |
| Normal-vs-AfricanAmerican |
9.162800E-01 |
| Normal-vs-Asian |
7.870800E-01 |
| Caucasian-vs-AfricanAmerican |
6.532600E-01 |
| Caucasian-vs-Asian |
6.396400E-01 |
| AfricanAmerican-vs-Asian |
9.319600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.717200E-01 |
| Normal-vs-Female |
2.873800E-01 |
| Male-vs-Female |
1.976400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.436000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.120000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.317400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.662100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.645600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.532200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.948010E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.741000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.719220E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.691790E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.010600E-01 |
| Classical-VS-Follicular |
1.172160E-02 |
| Classical-VS-Other |
5.834200E-01 |
| Classical-VS-Normal |
8.593000E-01 |
| Tall-VS-Follicular |
3.995200E-01 |
| Tall-VS-Other |
4.816200E-01 |
| Tall-VS-Normal |
5.136000E-01 |
| Follicular-VS-Other |
3.415800E-01 |
| Follicular-VS-Normal |
7.316100E-02 |
| Other-VS-Normal |
6.158800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.855000E-01 |
| Normal-vs-N1 |
2.268200E-01 |
| N0-vs-N1 |
7.691000E-01 |
|
|
